As a leading national provider of specialty infusion and pharmacy services, AOM Infusion has been named to the annual Inc. 5000 list, recognizing the nation’s fastest-growing private companies. AOM ranks No. 2,207 based on a three-year revenue growth of 153 percent. The list includes the country’s fastest growing private companies within the economy’s independent business sector.
Over the last three years, AOM has expanded its clinical footprint and capabilities by investing in top talent, developing strong partnerships with providers and payer networks, and continuing our commitment to innovation, collaboration, and operational excellence. This culminated in AOM Infusion being the first company recognized with the IgNS/ ACHC Distinction in Ig therapy.
This recognition isn’t just about numbers or rankings. It is a direct reflection of our commitment to improving health and enhancing lives. As we continue to expand our reach, we are bringing that same exceptional, individualized care experience to more patients in more communities across the country.
“Growth only matters if we can improve outcomes and consistently deliver the quality of care that got us here. Making the Inc. 5000 for a second year is validation that we can grow intentionally, expand access to our care model, and still deliver the exceptional experience our patients deserve,” said Keyur Mehta, CEO of AOM Infusion.
This milestone celebrates not only our growth, but our incredible team whose dedication and drive to patient care makes it all possible.
With the advent of AI innovation and ever-changing economic markets, business is constantly evolving. The Inc. 5000 honorees produced over $385 billion in revenue in 2025, demonstrating their ability and finesse in navigating this challenging environment. You can view the complete results of the Inc. 5000 and methodology for the rankings can be found at www.inc.com/inc5000.
